CCCC
C4 Therapeutics Inc
Price:  
1.71 
USD
Volume:  
1,567,005.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CCCC Intrinsic Value

-5,177.40 %
Upside

What is the intrinsic value of CCCC?

As of 2025-07-09, the Intrinsic Value of C4 Therapeutics Inc (CCCC) is (86.82) USD. This CCCC valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1.71 USD, the upside of C4 Therapeutics Inc is -5,177.40%.

The range of the Intrinsic Value is (300.75) - (51.73) USD

Is CCCC undervalued or overvalued?

Based on its market price of 1.71 USD and our intrinsic valuation, C4 Therapeutics Inc (CCCC) is overvalued by 5,177.40%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

1.71 USD
Stock Price
(86.82) USD
Intrinsic Value
Intrinsic Value Details

CCCC Intrinsic Value - Valuation Summary

Range Selected Upside
a
DCF (Growth 5y) (300.75) - (51.73) (86.82) -5177.4%
DCF (Growth 10y) (77.61) - (445.31) (129.71) -7685.5%
DCF (EBITDA 5y) (40.44) - (50.57) (1,234.50) -123450.0%
DCF (EBITDA 10y) (63.76) - (87.72) (1,234.50) -123450.0%
Fair Value -7.27 - -7.27 -7.27 -525.26%
P/E (19.93) - (39.12) (31.38) -1935.0%
EV/EBITDA (29.75) - (21.64) (28.97) -1794.0%
EPV (18.82) - (29.33) (24.07) -1507.8%
DDM - Stable (9.65) - (63.66) (36.65) -2243.5%
DDM - Multi (18.83) - (106.67) (33.05) -2033.0%

CCCC Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 121.43
Beta 2.42
Outstanding shares (mil) 71.01
Enterprise Value (mil) 70.13
Market risk premium 4.60%
Cost of Equity 10.31%
Cost of Debt 5.00%
WACC 7.65%